|
|
News Breaks | | | | July 13, 2012 | | 16:50 EDT |  | CTIC | Cell Therapeutics subsidiary enters master services agreement with Quintiles
Cell Therapeutics's wholly-owned subsidiary CTI Life Sciences entered into a master services agreement with Quintiles Commercial Europe. Pursuant to the terms of the agreement, Quintiles has agreed to provide market access services, promotion and detailing services, strategic planning, project management, pricing and reimbursement support, pharmacovigilance, medical information and other regulatory services and consulting advice to CTILS and its affiliates in relation to the commercialization of the company’s pharmaceutical product Pixuvri in certain agreed territories in Europe. Over the term of the agreement, the parties will execute separate project orders specifying the details of, without limitation, the services, fees, duration, termination and related terms and conditions. The agreement is effective from June 1, 2012 through December 31, 2015 or until terminated in accordance with its terms. | |
|
News For CTIC From The Last 14 Days Check below for free stories on CTIC the last two weeks. |
|
|
| May 20, 2013 | | 05:47 EDT | | CTIC | Cell Therapeutics reports the G-BA issues final assessment report for Pixuvri
 Subscribe for More Information | |
|
|
|
|
|
|
